The FDA has approved Apadaz for the short-term management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Parent- and nurse-controlled analgesia may not reduce postoperative pain in children with developmental delay compared with opioids administered by a nurse as needed.
Lidocaine infusions were shown to provide long-lasting and adequate analgesia in 41% of patients with chronic pain.
For patients presenting to the emergency department in pain, who are subsequently admitted to the hospital, the cost per hour in moderate or severe pain averted is higher for patient-controlled analgesia vs standard care.
The motivation for pain relief is higher in patients compared with healthy individuals.
Multiple psychosocial factors such as depression, anxiety, and pain catastrophizing are associated with opioid analgesic response.
Hypnotic analgesia has been linked with significant reductions in pain-related outcomes.
Connectivity in the right midfrontal gyrus may help predict placebo response.
"Our study shows that clinically significant placebo effects can be produced even when patients are told that they are being given placebos."
Researchers find male users report greater benefits compared to women
Common brain regions activated during meditation and pain
Peripheral anti-nociceptive effects of Substance P
Mu-Opioid Analgesic in Phase III Offers Hope for the Management of Chronic Pain Without Addictive Side EffectsJuly 22, 2016
Slowing entry through the blood-brain barrier
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Half of Patients Referred for Behavioral Treatment of Migraine Never Initiate Treatment
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness